Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018–2022.

MLA

Anwari, Palwasha, et al. “Post-Marketing Surveillance of Intussusception after Rotarix Administration in Afghanistan, 2018–2022.” Vaccine, vol. 42, no. 8, Mar. 2024, pp. 2059–64. EBSCOhost, https://doi.org/10.1016/j.vaccine.2024.02.057.

APA

Anwari, P., Burnett, E., Chavers, T. P., Samsor, A., Safi, H., Safi, N., Clark, A. D., Parashar, U. D., & Tate, J. E. (2024). Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018–2022. Vaccine, 42(8), 2059–2064. https://doi.org/10.1016/j.vaccine.2024.02.057

Chicago

Anwari, Palwasha, Eleanor Burnett, Tyler P. Chavers, Akmal Samsor, Helah Safi, Najibullah Safi, Andrew D Clark, Umesh D. Parashar, and Jacqueline E. Tate. 2024. “Post-Marketing Surveillance of Intussusception after Rotarix Administration in Afghanistan, 2018–2022.” Vaccine 42 (8): 2059–64. doi:10.1016/j.vaccine.2024.02.057.